Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly in the development of central nervous system agents. Its structure supports activity as a modulator of neurotransmitter receptors, making it valuable in the design of antidepressants and antipsychotics. Also employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the stability and polarity imparted by the trifluoromethoxy and morpholine groups. Commonly found in early-stage drug discovery programs targeting neurological disorders.